Comorbidities and bleeding pattern in elderly haemophilia A patients
Authors:
- 24 June 2009
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 15 (4) , 894-899
Abstract
Summary. The increasing numbers of comorbidities related to higher age and their treatment constitute a challenge in the treatment of haemophiliacs. Comparing prevalences of morbidities in the elderly haemophilia A population (n = 29) and the general elderly population of Germany reveals some differences. HCV infections are more frequent in the elderly haemophilia population (69% vs. 0.6%). Prevalence of cancer was five times higher than in the age matched general population (28% vs. 5.2%). Cardiac diseases seem to be less frequent although the prevalences of cardiovascular risk factors like hypertension, diabetes, and body mass index (BMI) >25 do not differ in comparison to the general population. A reduction of bleeding symptoms or dosage of FVIII could not be observed. There is a tendency of increasing bleeding symptoms with increasing age of the patients due to more frequent spontaneous joint bleedings, malignancies or treatment with phenprocoumon or ASA. In consequence, FVIII dosage had to be increased in eight patients (28%). Our patient population at the age >60 years is very small and no statistical evidence can be shown, therefore appropriate treatment of elderly haemophiliacs needs further evaluation in multicentre studies with sufficient patient numbers.Keywords
This publication has 17 references indexed in Scilit:
- Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIVBlood, 2007
- Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort studyJournal of Thrombosis and Haemostasis, 2006
- Non‐Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection†Hepatology, 2005
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- Effects of HIV infection on age and cause of death for persons with hemophilia A in the United StatesAmerican Journal of Hematology, 2001
- Natural history of hepatitis C: Its impact on clinical managementHepatology, 2000
- Hepatitis C Virus Infection and Extrahepatic MalignanciesJournal of Clinical Gastroenterology, 1997
- Hepatitis C antibody and chronic liver disease in haemophiliaThe Lancet, 1990
- Mortality and causes of death in Dutch haemophiliacs, 1973–86British Journal of Haematology, 1989
- Life expectancy of Swedish haemophiliacs, 1831–1980British Journal of Haematology, 1985